Fetal and neonatal alloimmune thrombocytopenia.
(2016) In Seminars in Fetal & Neonatal Medicine 21(1). p.19-27- Abstract
- Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an alloimmune disorder resulting from platelet opsonization by maternal antibodies that destroy fetal platelets. The major risk of FNAIT is severe bleeding, particularly intracranial hemorrhage. Miscarriage has also been reported but the incidence requires further study. Analogous to adult autoimmune thrombocytopenia (ITP), the major target antigen in FNAIT is the platelet membrane glycoprotein (GP)IIbIIIa. FNAIT caused by antibodies against platelet GPIbα or other antigens has also been reported, but the reported incidence of the anti-GPIbα-mediated FNAIT is far lower than in ITP. To date, the maternal immune response to fetal platelet antigens is still not well understood and it... (More)
- Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an alloimmune disorder resulting from platelet opsonization by maternal antibodies that destroy fetal platelets. The major risk of FNAIT is severe bleeding, particularly intracranial hemorrhage. Miscarriage has also been reported but the incidence requires further study. Analogous to adult autoimmune thrombocytopenia (ITP), the major target antigen in FNAIT is the platelet membrane glycoprotein (GP)IIbIIIa. FNAIT caused by antibodies against platelet GPIbα or other antigens has also been reported, but the reported incidence of the anti-GPIbα-mediated FNAIT is far lower than in ITP. To date, the maternal immune response to fetal platelet antigens is still not well understood and it is unclear why bleeding is more severe in FNAIT than in ITP. In this review, we introduce the pathogenesis of FNAIT, particularly those new discoveries from animal models, and discuss possible improvements for the diagnosis, therapy, and prevention of this devastating disease. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8573682
- author
- Zdravic, Darko ; Yougbare, Issaka ; Vadasz, Brian ; Li, Conglei ; Marshall, Alexandra H ; Chen, Pingguo ; Kjeldsen-Kragh, Jens LU and Ni, Heyu
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Antibody-induced immune suppression, Fetal and neonatal alloimmune thrombocytopenia, Intraveneous immunoglobulin G, Platelets
- in
- Seminars in Fetal & Neonatal Medicine
- volume
- 21
- issue
- 1
- pages
- 19 - 27
- publisher
- Elsevier
- external identifiers
-
- pmid:26810319
- scopus:84957439805
- wos:000370906100004
- pmid:26810319
- ISSN
- 1878-0946
- DOI
- 10.1016/j.siny.2015.12.004
- language
- English
- LU publication?
- yes
- id
- 13202ab3-2bda-46b3-9e16-ee0e61bb49fe (old id 8573682)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26810319?dopt=Abstract
- date added to LUP
- 2016-04-01 11:05:50
- date last changed
- 2024-10-07 20:22:07
@article{13202ab3-2bda-46b3-9e16-ee0e61bb49fe, abstract = {{Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an alloimmune disorder resulting from platelet opsonization by maternal antibodies that destroy fetal platelets. The major risk of FNAIT is severe bleeding, particularly intracranial hemorrhage. Miscarriage has also been reported but the incidence requires further study. Analogous to adult autoimmune thrombocytopenia (ITP), the major target antigen in FNAIT is the platelet membrane glycoprotein (GP)IIbIIIa. FNAIT caused by antibodies against platelet GPIbα or other antigens has also been reported, but the reported incidence of the anti-GPIbα-mediated FNAIT is far lower than in ITP. To date, the maternal immune response to fetal platelet antigens is still not well understood and it is unclear why bleeding is more severe in FNAIT than in ITP. In this review, we introduce the pathogenesis of FNAIT, particularly those new discoveries from animal models, and discuss possible improvements for the diagnosis, therapy, and prevention of this devastating disease.}}, author = {{Zdravic, Darko and Yougbare, Issaka and Vadasz, Brian and Li, Conglei and Marshall, Alexandra H and Chen, Pingguo and Kjeldsen-Kragh, Jens and Ni, Heyu}}, issn = {{1878-0946}}, keywords = {{Antibody-induced immune suppression; Fetal and neonatal alloimmune thrombocytopenia; Intraveneous immunoglobulin G; Platelets}}, language = {{eng}}, number = {{1}}, pages = {{19--27}}, publisher = {{Elsevier}}, series = {{Seminars in Fetal & Neonatal Medicine}}, title = {{Fetal and neonatal alloimmune thrombocytopenia.}}, url = {{http://dx.doi.org/10.1016/j.siny.2015.12.004}}, doi = {{10.1016/j.siny.2015.12.004}}, volume = {{21}}, year = {{2016}}, }